Analystreport

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report